![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 9/24 | |
A61K 31/155 | |||
A61K 31/70 | |||
A61K 31/7034 | |||
A61K 31/7042 | |||
A61K 31/7004 | |||
A61K 31/403 | |||
A61K 45/06 | |||
A61P 3/00 | |||
A61P 3/04 | |||
A61P 3/06 | |||
A61P 3/10 | |||
A61P 5/50 | |||
A61P 9/10 | |||
A61P 9/12 | |||
A61P 13/12 | |||
A61P 17/02 | |||
A61P 25/00 | |||
A61P 27/02 | |||
A61P 27/12 | |||
A61P 43/00 | |||
A61K 9/20 |
(11) | Patento numeris | 3315124 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17206106.1 |
Europos patento paraiškos padavimo data | 2010-11-12 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-05-02 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-06 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
261087 P | 2009-11-13 | US |
(72) |
ABEBE, Admassu, US
MARTIN, Kyle, US
PATEL, Jatin M., US
DESAI, Divyakant, US
TIMMINS, Peter, US
|
(73) |
AstraZeneca UK Limited,
1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge CB2 0AA,
GB
Astrazeneca AB, 151 85 Södertälje, SE |
(54) | BILAYER TABLET FORMULATIONS |
BILAYER TABLET FORMULATIONS |